Major haemorrhage guide history

Document Title

Clinical Guideline for the Management of a Major Haemhorrage/Catastrophic Bleed for Palliative Care patients

Document Date

July 2024

Document Purpose and Intended Audience

This guideline has been produced to provide a clear framework to
ensure the safe and effective care of a patient at the end of life who suffers a catastrophic bleed in both an inpatient and community setting.

Author

St Giles Hospice (Dr Nial McCarron, Katie Taroni, Toni Flanagan,
Jane Mogford)
Dr Brenda Ward
Update Dr Anna Lock 2021
Update Dr Katie Shellis and Tricia Evans 2024
Update Dr Louise Hills and Dr Nicky Baker 2024

Consultation Process

Endorsed and approved by SPAGG

Monitoring

This will be audited and reviewed every 3 years

Review Date

(must be within three years)

July 2027

Approval Signatures:

SPAGG chair

Dr Jon Tomas

SPAGG secretary

Dr Alice Gray

Date Approved by SPAGG: July 2024

Date submitted to Area Prescribing Committee: N/A

Version History

Version 1

Date

September 2015

Summary of change/ process

Endorsed and approved by SPAGG

Version 2

Date

September 2018

Summary of change/ process

Reviewed

Version 3

Date

February 2024

Summary of change/ process

Reviewed

Version 4

Date

June 2024

Summary of change/ process

Reviewed

Disclaimer

These Guidelines are intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.

Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.

Whilst SPAGG takes every care to compile accurate information , we cannot guarantee its correctness and completeness, and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.